• ILMN is trading 4.1% up now at $182.98, with gains driven by fresh bullish analyst commentary from Guggenheim and Piper Sandler.
  • Both Guggenheim and Piper Sandler raised their price targets to $200 on July 1, 2026, with Guggenheim reiterating a Buy rating and Piper Sandler maintaining an Overweight rating.
  • The positive sentiment follows strong Q1 2026 results, where Illumina exceeded earnings and revenue estimates and raised its full-year 2026 outlook.